United States News All stories

NorthStrive Defense Tech (NASDAQ:ELAB) has moved to bolster its maritime and littoral combat portfolio, announcing it has secured an exclusive option to license a specialized multi-domain drone system under U.S. Patent No. 12,291,334.

Deckorators, a leading brand of UFP Industries (NYSE:UFPI), has completed the acquisition of the remaining operating assets for MoistureShield decking, significantly expanding its manufacturing footprint and proprietary technology portfolio in the high-growth wood-plastic composite (WPC) market.

Jet.AI (NASDAQ:JTAI), a developer of artificial intelligence-driven software for the private aviation industry, has announced a 1-for-200 reverse stock split effective before the market opens on April 8, 2026.

Oncolytics Biotech (NASDAQ:ONCY) has scheduled a Type C meeting with the U.S. Food and Drug Administration (FDA) for April 16, 2026, to align on a formal registrational development path for its lead immunotherapy candidate, pelareorep, in patients with advanced anal cancer.

Mobix Labs (NASDAQ:MOBX), a fabless semiconductor and connectivity company, has been awarded a $3.2 million order for mission-critical technology integrated into the airport body scanners utilized by the Transportation Security Administration (TSA) across the United States.

Stereotaxis (NYSE:STXS), a pioneer in innovative robotic technologies for the treatment of cardiac arrhythmias, announced on April 6, 2026, that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Synchrony™ interventional lab display system.

ParaZero Technologies (NASDAQ:PRZO), an aerospace defense company specializing in autonomous drone safety and interception solutions, has received a follow-on purchase order from an Israeli defense entity for its advanced DefendAir Counter-Unmanned Aerial Systems (C-UAS).

FuboTV (NYSE:FUBO) has unveiled a robust multi-year financial roadmap, setting its sights on significant profitability milestones as the company matures from a high-growth streaming challenger into a scaled, cash-generative media platform.

Amgen (NASDAQ:AMGN) has announced positive topline results from its Phase 3 clinical trial evaluating a subcutaneous formulation of TEPEZZA (teprotumumab-trbw) for adults with moderate-to-severe active Thyroid Eye Disease (TED).

Elbit Systems (NASDAQ:ESLT) has been awarded a contract valued at approximately $750 million (€650 million) to supply its Precise & Universal Launching System (PULS) rocket artillery to the Hellenic Armed Forces, marking a major expansion of the company’s presence in the European defense market.

Nuvini (NASDAQ:NVNI) has announced a definitive agreement to acquire a 51% controlling interest in the American business of Beyondsoft, a strategic move designed to scale its international technology platform and significantly expand its footprint in the Western Hemisphere.

ProCap Financial (NASDAQ:BRR), the first publicly traded agentic finance firm, has announced the successful completion of its acquisition of CFO Silvia, an artificial intelligence model and agent lab specialized exclusively in financial applications.

Sunshine Biopharma (NASDAQ:SBFM) has filed its Form 10-K for the fiscal year ended December 31, 2025, reporting a steady increase in top-line revenue alongside a significant expansion of its generic drug portfolio.

Corpay (NYSE:CPAY), a global leader in corporate payments, has officially completed the sale of its mobile parking payment subsidiary, PayByPhone, to the private equity firm Lightyear Capital.

Inspira Technologies (NASDAQ:IINN) has reached a definitive agreement to acquire the Additive Manufacturing Electronics (AME) platform from Nano Dimension, marking a significant expansion of its technical capabilities and intellectual property portfolio.

AMC Entertainment (NYSE:AMC), the world's largest theatrical exhibitor, delivered a record-setting performance over the 2026 Easter holiday weekend, achieving the highest combined global admissions and concessions revenue for the holiday frame in the company’s 106-year history.

Halliburton (NYSE:HAL) has entered into a strategic collaboration agreement with PETRONAS Suriname Exploration & Production BV and Valaris to accelerate the development of offshore assets in Suriname through an integrated, early-lifecycle engagement model.

Oracle (NYSE:ORCL) has named Hilary Maxson as its new Chief Financial Officer, effective April 6, 2026, placing a veteran of capital-intensive industries at the helm of its finance organization during the most significant infrastructure expansion in the company's history.

Medicus Pharma (NASDAQ:MDCX) has reached a critical regulatory milestone, submitting an optimized Phase 2 clinical trial protocol to the U.S. Food and Drug Administration (FDA) for its lead candidate, Teverelix, aimed at preventing recurrent acute urinary retention (AURr) in men with benign prostatic hyperplasia (BPH).

Capstone Holding (NASDAQ:CAPS), a tech-enabled building products distribution platform, has secured a significant expansion of its portfolio through a new distribution agreement for Eldorado Stone, a premium manufactured stone veneer brand from Westlake Royal Building Products.

Hillman Solutions (NASDAQ:HLMN), a leading provider of hardware and home improvement solutions, has completed the acquisition of Campbell Chain & Fittings from Apex Tool Group, a move that significantly broadens the company’s industrial Maintenance, Repair, and Operations (MRO) portfolio.

DeFi Technologies (NASDAQ:DEFT) reported record-breaking financial results for the fiscal year ended December 31, 2025, as the firm’s diversified digital asset strategy and recent acquisitions drove a significant expansion in both top-line revenue and net profitability.

Sharps Technology (NASDAQ:STSS) has reported its 2025 year-end results, revealing a comprehensive structural transformation from a medical device manufacturer into a digital asset-focused treasury holding company centered on the Solana ecosystem.

Sagimet Biosciences (NASDAQ:SGMT) announced today that it will present updated results from its Phase 2b FASCINATE-2 clinical trial at the Fueling MASH Keystone Symposium, held April 12-15, 2026, in Vancouver, British Columbia.